Latest stories on CHRS
Baker Hughes Boosts Outlook on Chart Industries Acquisition
MarketWatch67 · bullishm&a
Coherus to Participate in Upcoming Investor Conferences
GlobeNewswire55 · neutralgeneral
Coherus Biosciences Launches $50 Million ATM Equity Program
TipRanks28 · bearishgeneral
Coherus Oncology, Inc. (CHRS) files 8-K
SEC 8-K50 · neutralgeneral
Coherus: 'Hold' On Several Tagmokitug 2026 Catalysts And Casdozokitug HCC Drug Development
Seeking Alpha46 · neutralproduct/pr
Coherus Announces Special Dividend of Contingent Value Rights: Sharpened Focus on Oncology, Shareholder Value in Spotlight
MarketChameleon58 · neutralgeneral
Coherus Oncology issuing special dividend of biosimilar contingent value rights
The Fly50 · neutralgeneral
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
GlobeNewswire50 · neutralgeneral
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
StockTitan50 · neutralgeneral
Coherus Oncology, Inc. (CHRS) files 8-K
SEC 8-K50 · neutralgeneral
Coherus Oncology, Inc. (CHRS) files 8-K
SEC 8-K50 · neutralgeneral
Coherus Oncology (CHRS) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Chorus Aviation Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Coherus Oncology Price Target Lowered To 10 From 12 At Guggenheim
The Fly38 · neutralanalyst
Coherus Oncology, Inc. (CHRS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Coherus Oncology Q2 Earnings Call Highlights
Yahoo Finance58 · neutralearnings
Coherus Oncology, Inc. (CHRS) files 8-K
SEC 8-K50 · neutralgeneral
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update
StockTitan34 · bearishearnings
e.l.f. and Bubble Launch Limited-Edition Hybrid Holy Grails in Skincare-Makeup Collaboration
StockTitan57 · neutralproduct/pr
Coherus Oncology: The Catalyst Rich Period Is Here
Seeking Alpha67 · bullishanalyst
Chart Industries, Inc. Q2 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
StockTitan50 · neutralgeneral